Medicare Enrolled

Dr. Jonathan Reitman, M.D.

Addiction Medicine (Internal Medicine) Physician · Beverly Hills, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
8484 WILSHIRE BLVD, Beverly Hills, CA 90211
3103607690
In practice since 2007 (19 years)
NPI: 1922157320 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Reitman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Reitman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Reitman

Dr. Jonathan Reitman is an addiction medicine physician in Beverly Hills, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Reitman performed 1,518 Medicare services across 489 unique beneficiaries.

Between the years covered by Open Payments, Dr. Reitman received a total of $11,809 from 50 pharmaceutical and/or device companies across 599 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in addiction medicine (internal medicine) physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Reitman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 7% volume in CA $11,809 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,518
Medicare services
Top 7% in CA for addiction medicine (internal medicine) physician
489
Unique beneficiaries
$82
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~80 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
516 $76 $300
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
358 $101 $225
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
204 $68 $200
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
128 $135 $400
Hospital discharge day management, 30 minutes or less
This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less.
104 $70 $300
45-minute psychotherapy and evaluation visit
A 45-minute session that includes both psychotherapy and an evaluation and management visit.
89 $71 $350
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
51 $42 $200
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
47 $48 $280
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
21 $21 $200
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$11,809
Total received (2018-2024)
Avg $1,687/year across 7 years
Top 17% in CA for addiction medicine (internal medicine) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
599
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,726 (99.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$83 (0.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,976
2023
$1,692
2022
$1,176
2021
$1,817
2020
$1,168
2019
$2,094
2018
$1,887

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$402
ABBVIE INC.
$339
Gilead Sciences, Inc.
$321
ViiV Healthcare Company
$310
Indivior Inc.
$170
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$94
IDORSIA PHARMACEUTICALS US INC
$56
Amgen Inc.
$54
Lundbeck LLC
$52
Takeda Pharmaceuticals U.S.A., Inc.
$47
Napo Pharmaceuticals Inc
$46
EMD Serono, Inc.
$34
Vanda Pharmaceuticals Inc.
$29
Lilly USA, LLC
$21
Top 3 companies account for 53.7% of 2024 payments
All-time payments by company (2018-2024) ›
Gilead Sciences, Inc.
$2,144
ViiV Healthcare Company
$1,357
AbbVie Inc.
$989
ABBVIE INC.
$855
EMD Serono, Inc.
$466
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$427
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$402
Theratechnologies Inc.
$370
Indivior Inc.
$349
AbbVie, Inc.
$348
Otsuka America Pharmaceutical, Inc.
$341
Janssen Biotech, Inc.
$340
Sunovion Pharmaceuticals Inc.
$318
Orexo US, Inc.
$309
Takeda Pharmaceuticals U.S.A., Inc.
$286
Napo Pharmaceuticals Inc
$242
Lundbeck LLC
$220
Neurocrine Biosciences, Inc.
$215
IDORSIA PHARMACEUTICALS US INC
$195
Merck Sharp & Dohme Corporation
$187
Teva Pharmaceuticals USA, Inc.
$136
Lilly USA, LLC
$130
Neuronetics, Inc.
$112
ITI, Inc.
$106
Janssen Pharmaceuticals, Inc
$85
Vanda Pharmaceuticals Inc.
$84
Allergan, Inc.
$82
Allergan Inc.
$81
Axsome Therapeutics, Inc.
$77
Amgen Inc.
$69
AstraZeneca Pharmaceuticals LP
$69
Merck Sharp & Dohme LLC
$39
PFIZER INC.
$34
US WorldMeds, LLC
$33
Antares Pharma, Inc.
$28
SCILEX PHARMACEUTICALS INC.
$25
Alkermes, Inc.
$25
Shionogi Inc
$21
Shire North American Group Inc
$20
Biohaven Pharmaceutical Holding Company Ltd.
$20
Biohaven Pharmaceuticals, Inc.
$20
Tris Pharma Inc
$19
Astellas Pharma US Inc
$19
CSL Behring
$19
Optos, Inc.
$18
USWM, LLC
$17
Alfasigma USA, Inc.
$17
Sentynl Therapeutics, Inc.
$17
Vertical Pharmaceuticals, LLC
$16
Eisai Inc.
$13
Top 3 companies account for 38.0% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ABILIFY MYCITE · AJOVY · APRETUDE · Austedo XR · Auvelity · BELSOMRA · BREZTRI · BRINTELLIX · Biktarvy · CABENUVA · CAPLYTA · CHANTIX · DOVATO · Dayvigo · Dyanavel XR · EGRIFTA · EMGALITY · FANAPT · Fanapt · Hizentra · INGREZZA · INVEGA SUSTENNA · ISENTRESS · JULUCA · LATUDA · LUCEMYRA · Levorphanol · Lucemyra/Lofexidine · MAVYRET · MOUNJARO · MOVANTIK · MYRBETRIQ · Mavyret · Mytesi · NEUROSTAR TMS THERAPY SYSTEM · NURTEC ODT · Otezla · Otrexup · PANORAMIC OPHTHALMOSCOPE · PERSERIS · PIFELTRO · PREZCOBIX · PREZISTA · QULIPTA · QUVIVIQ · RELEXXII · RELISTOR · REXULTI · SEROSTIM · SPRAVATO · SUBLOCADE · SUBOXONE SUBLINGUAL FILM · SYMTUZA · Serostim · Symproic · Symtuza · TRINTELLIX · TRIUMEQ · TROGARZO · TRULICITY · Trintellix · UBRELVY · UZEDY · VRAYLAR · VYVANSE · Vivitrol · XIFAXAN · XYOSTED · ZIMHI · ZTLido · Zubsolv
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an addiction medicine physician in Beverly Hills?
Compare addiction medicine physicians in the Beverly Hills area by procedure volume, costs, and industry payment transparency.
Browse addiction medicine physicians nearby

Geographic Context

Addiction medicine physicians within 10 mi
15
Per 100K population
0.2
County median income
$87,760
Nearest hospital
CEDARS-SINAI MEDICAL CENTER
0.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Reitman is a clinical cardiology specialist, with above-average Medicare volume (top 7% in CA), with low-engagement industry engagement in the top 17% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Reitman experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Reitman performed 516 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Reitman receive payments from pharmaceutical companies?
Yes. Dr. Reitman received a total of $11,809 from 50 companies across 599 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Reitman's costs compare to other addiction medicine physicians in Beverly Hills?
Dr. Reitman's average Medicare payment per service is $82. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Reitman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →